• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall Alaris PC Unit

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
 Class 2 Device Recall Alaris PC Unitsee related information
Date Initiated by FirmJanuary 24, 2023
Date PostedMarch 01, 2023
Recall Status1 Open3, Classified
Recall NumberZ-1192-2023
Recall Event ID 91582
510(K)NumberK072105 
Product Classification Pump, infusion - Product Code FRN
ProductAlaris PC Unit 8015 utilizing 802.11 b/g or 802.11 a/b/g wireless network cards, with IP addresses from x.x.x.224 to x.x.x.255
Code Information All PC Units, UDI-DI: 10885403801549, 10885403801532, with software versions 12.1.0, 12.1.2, 12.1.3, utilizing affected network cards and IP addresses
Recalling Firm/
Manufacturer
CareFusion 303, Inc.
10020 Pacific Mesa Blvd
San Diego CA 92121-4386
Manufacturer Reason
for Recall
Infusion pump PCs with specific software/network cards/IP addresses can have network/wireless connection failure. Could cause inability to receive new datasets and inability to transfer retrospective analytics data to connected systems. Users with interfaces to electronic medication record or admin discharge transfer, may be unable to receive/send data; infusions may need to be manually programmed
FDA Determined
Cause 2
Software Design Change
ActionOn 01/24/23, notices were mailed to customers, who were told to do the following: 1) Inspect the back of the PC Unit and observe the wireless card. Wireless cards that protrude out of the PC Unit are impacted. 2) Software version can be seen on the PCU using the following steps: a) Press Options Key, b) Press Page Down soft key, c) Press Software Versions soft key to display Software Versions menu, d) Press View soft key for the PCU. To prevent this issue from occurring, do one of the following: 1. Exclude IP address ranges ending in x.x.x.224 to x.x.x.255 from all the DHCP scopes where the affected PC Units are being utilized. 2. Assign the affected PC Units IP addresses utilizing DHCP reservations to prevent the PC Unit from obtaining an IP address in the aforementioned range. 3. Assign the affected PC Units a static IP address outside of the aforementioned range. Actions for Clinical Users: Check if wireless icon is illuminated. If the PC Unit is not connected to the wireless network when using Interoperability, the clinical user can input all infusion parameters manually. In addition, the clinical end user can manually document the infusion in the EMR. Data sets can also manually be programmed or uploaded to the PC unit using a serial cable. Continue to rely on hospital established protocols for wireless downtime procedures. Customers who require additional assistance can contact: Customer Order Management, 1-800-482-4822, GMB-CTS-CustCareInfusion@bd.com; Technical Support, 1-866-488-1408, DL-US-INF-TechSupport@bd.com; Clinical & Pharmacy Support, 1-858-617-1316, GMB-AlarisMedSafetyProgram@bd.com; BD Designated Complaint Handling Unit, 1-888-812-3266, productcomplaints@bd.com Complete and return the customer response form to BDRC39@bd.com
Quantity in Commerce83,185
DistributionUS: FL, CA, OR, IL, WI, NJ, AZ, NV, CO, WY, NE, TX, MI, VA, OH, NC, LA, NM, AL, TN, AR, PA, CT, IN, KS, GA, SC, MD, UT, MA, DC, OK, IA, NY, WA, SD, ND, MN, KY, MO, WV, MS, DE, ME, MT, ID, NH, HI, AK, VT OUS: Canada, Qatar, Saudi Arabia,, Kuwait, United Arab Emirates, Israel, South Africa, Zimbabwe, Botswana, Australia, New Zealand
Total Product Life CycleTPLC Device Report

1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
510(K) Database510(K)s with Product Code = FRN
-
-